https://www.pharma-marketing.com/germany-backs-away-from-variable-drug-discount-plan/Pharma-Marketing.comen2026-06-16T09:11:48+00:00Germany backs away from variable drug discount plan https://www.pharma-marketing.com/de/deutschland-rueckt-von-variablen-arzneirabatten-ab/Pharma-Marketing.comde2026-06-16T09:11:47+00:00Deutschland rückt von variablen Arzneirabatten ab https://www.pharma-marketing.com/kathrin-rezac-takes-over-brand-communications-at-reviderm/Pharma-Marketing.comen2026-06-16T08:54:14+00:00Kathrin Rezac takes over brand communications at Reviderm https://www.pharma-marketing.com/de/kathrin-rezac-uebernimmt-markenkommunikation-bei-reviderm/Pharma-Marketing.comde2026-06-16T08:54:13+00:00Kathrin Rezac übernimmt Markenkommunikation bei Reviderm https://www.pharma-marketing.com/comprix-2026-scholz-friends-leads-the-winners-list/Pharma-Marketing.comen2026-06-14T11:44:11+00:00Comprix 2026: Scholz & Friends leads the winners list https://www.pharma-marketing.com/de/comprix-2026-scholz-friends-fuehrt-gewinnerfeld-an/Pharma-Marketing.comde2026-06-14T11:44:11+00:00Comprix 2026: Scholz & Friends führt Gewinnerfeld an